Psychiatry play

Rules-Based Medicine Inc., a 2002 spinout from biological testing company Luminex Corp. (NASDAQ:LMNX), last week filed for an IPO to raise up to $90 million.

RBM is hoping to use the proceeds to launch its Psychiatric Diagnostic Panel, a CLIA-certified, 51-biomarker test to identify patients with recent-onset schizophrenia...